⌘K

Login Start Free

Home/Filings/4/0001415889-24-002756

4//SEC Filing

Longpre Lara 4

Accession 0001415889-24-002756

CIK 0001759425other

View on SEC.gov Company Profile

Filed

Feb 4, 7:00 PM ET

Accepted

Feb 5, 9:10 PM ET

Size

4.8 KB

Accession

0001415889-24-002756

Insider Transaction Report

Form 4

Period: 2024-02-02

Mirum Pharmaceuticals, Inc.MIRM

Chief Development Officer

Transactions

Sale
Common Stock
2024-02-02$26.19/sh−847$22,184→ 104,407 total

Footnotes (1)

[F1]Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units.

Documents

1 file

4
form4-02062024_020236.xmlPrimary

Issuer

Mirum Pharmaceuticals, Inc.

CIK 0001759425

Entity typeother

Related Parties

1

filerCIK 0001780347

Filing Metadata

Form type: 4
Filed: Feb 4, 7:00 PM ET
Accepted: Feb 5, 9:10 PM ET
Size: 4.8 KB

View on SEC.gov